LC
Laura Chico Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
71
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
75.4%
Neutral
17.5%
Negative
7%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Consumer Discretionary
Residential Construction
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $63 |
20%
upside
| 3 | +24% |
0
%
| 16 Mar ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $58 |
139%
upside
| 3 | +72% |
0
%
| 16 Mar ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $17 |
131%
upside
| 4 | +40% |
0
%
| 12 Mar ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $103 |
25%
upside
| 8 | +21% |
0
%
| 12 Mar ‘26 3 months ago |
|
|
|
Outperform
Reiterated
| $44 |
170%
upside
| 2 | -4.5% |
0
%
| 11 Mar ‘26 3 months ago |
|
|
|
Outperform
Reiterated
| $24 |
49%
upside
| 4 | +16% |
0
%
| 9 Mar ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $14 |
22%
upside
| 2 | -0.12% |
0
%
| 6 Mar ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $12 |
234%
upside
| 4 | +19% |
0
%
| 3 Mar ‘26 3 months ago |
|
|
|
Neutral
Maintained
| $18 |
56%
downside
| 1 | – |
–
| 25 Feb ‘26 3 months ago |
|
|
|
Neutral
Downgraded
| $1 |
499%
upside
| 3 | +13% |
0
%
| 24 Feb ‘26 3 months ago |
|
|
|
Outperform
Reiterated
| $19 |
235%
upside
| 3 | +18% |
0
%
| 23 Feb ‘26 3 months ago |
|
|
|
Underperform
Maintained
| $130 |
51%
downside
| 5 | -77% |
0
%
| 20 Feb ‘26 3 months ago |
|
|
|
Neutral
Reiterated
| $25 |
1%
downside
| 2 | – |
–
| 17 Feb ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $151 |
5%
downside
| 2 | -2.2% |
0
%
| 12 Feb ‘26 4 months ago |
|
|
|
Neutral
Maintained
| $187 |
6%
downside
| 4 | – |
–
| 10 Feb ‘26 4 months ago |
|
|
|
Outperform
Maintained
| $36 |
20%
upside
| 3 | +40% |
0
%
| 12 Jan ‘26 5 months ago |
|
|
|
Outperform
Maintained
| $30 |
35%
upside
| 3 | +17% |
0
%
| 11 Dec ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $33 |
4%
downside
| 2 | – |
–
| 11 Dec ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $30 |
5%
downside
| 3 | +21% |
0
%
| 13 Nov ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $32 |
9%
downside
| 2 | +52% |
0
%
| 7 Nov ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| $13 |
3%
upside
| 1 | +79% |
–
| 15 Oct ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $8 |
423%
upside
| 2 | +46% |
0
%
| 30 Sep ‘25 8 months ago |
|
|
|
Neutral
Downgraded
| $48 |
0%
upside
| 1 | +77% |
–
| 9 Sep ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $32 |
41%
downside
| 3 | +16% |
0
%
| 7 Aug ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $18 |
99%
upside
| 1 | -2.7% |
0
%
| 30 Jun ‘25 11 months ago |
|